Guan, Yanfen
Nguyen, Allison M.
Wratten, Samantha
Randhawa, Sharan
Weaver, Jessica
Arbelaez, Felipe
Fauconnier, Arnaud
Panter, Charlotte
Funding for this research was provided by:
Merck
Article History
Received: 21 September 2021
Accepted: 28 December 2021
First Online: 15 January 2022
Declarations
:
: Ethical approval and oversight was provided by Copernicus IRB, a centralized IRB in the US. Ethical approval for Stages 1 and 2 was received on 21st September 2018 (IRB tracking number: 420180415). Ethical approval for Stage 3 was received on 29th May 2020 (IRB tracking number: 20201445). Written informed consent was obtained prior to any study activities at each stage of this study. Consent was confirmed verbally at the beginning of each interview, as captured on the audio recording.
: Dissemination of findings including via publication was included in the Information and Consent/Assent Form signed by all participants (and the parent/legal guardian of adolescent participants).
: CP, SW, and SR are employees of Adelphi Values, a health outcomes research agency, commissioned by Merck to conduct this study.